TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) EBITDA Margin (2023)

Updated

TFA Therapeutics' EBITDA Margin was 5.47% in FY2025, down 13.69 percentage points from 19.16% in FY2024.

Analysis

TFA Therapeutics (RAJAF) EBITDA Margin (2023) Analysis & Trends

From FY2020 onward, TFA Therapeutics has reported EBITDA Margin for 6 years.

  • EBITDA Margin shows a five-year change of -20.78 percentage points (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual EBITDA Margin since FY2022.
  • Per Business Quant data, EBITDA Margin in earlier years was 19.16% in FY2024 (-22.86 pp), 42.02% in FY2023 (+668.55 pp), -626.53% in FY2022 (-630.48 pp) and 3.96% in FY2021 (-22.30 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Procter & Gamble 389.00 Bn 344.76 Bn 10.28 Bn 22.46%
2 Colgate Palmolive 77.52 Bn 72.25 Bn 3.30 Bn 21.84%
3 Estee Lauder Companies 39.14 Bn 27.21 Bn 2.74 Bn 4.38%
4 Kenvue 37.80 Bn 33.41 Bn 2.30 Bn 21.34%
5 Kimberly Clark 36.88 Bn 34.08 Bn 1.60 Bn 19.10%
6 Church & Dwight 25.69 Bn 24.22 Bn 693.90 Mn 25.03%
7 Clorox 10.68 Bn 8.96 Bn 804.00 Mn 28.34%
8 e.l.f. Beauty 6.75 Bn 5.73 Bn 398.84 Mn 26.91%
9 Reynolds Consumer Products 4.92 Bn 4.59 Bn 245.00 Mn 18.01%
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 55.84%
API Access

TFA Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RAJAF&period=max&api_key=YOUR_API_KEY